11-Hydroxysugiol
11-Hydroxysugiol regulates the SUMOylation of intracellular receptors by modulating RARα and vitamin D3 receptor (VDR).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 88664-08-8
- Formel: C20H28O3
- Molecular Weight:316.43
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | GI50 |
35.04 μM
Compound: 12
|
Cytotoxicity against human A549 cells assessed as growth inhibition by WST-8 assay
Cytotoxicity against human A549 cells assessed as growth inhibition by WST-8 assay
|
[PMID: 24210499] |
| A549 | IC50 |
>10 μM
Compound: 16
|
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTS assay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTS assay
|
[PMID: 33978415] |
| BEAS-2B | IC50 |
>10 μM
Compound: 16
|
Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay
Cytotoxicity against human BEAS2B cells assessed as reduction in cell viability after 48 hrs by MTS assay
|
[PMID: 33978415] |
| BXPC-3 | GI50 |
45.01 μM
Compound: 12
|
Cytotoxicity against human BxPC3 cells assessed as growth inhibition by WST-8 assay
Cytotoxicity against human BxPC3 cells assessed as growth inhibition by WST-8 assay
|
[PMID: 24210499] |
| HeLa | IC50 |
39.6 μM
Compound: 8
|
Cytotoxicity against human HeLa cells in lag phase of growth after 48 hrs
Cytotoxicity against human HeLa cells in lag phase of growth after 48 hrs
|
[PMID: 24709561] |
| HeLa | IC50 |
41.1 μM
Compound: 8
|
Cytotoxicity against human HeLa cells in log phase of growth after 48 hrs
Cytotoxicity against human HeLa cells in log phase of growth after 48 hrs
|
[PMID: 24709561] |
| HEp-2 | IC50 |
46.2 μM
Compound: 8
|
Cytotoxicity against human Hep2 cells in log phase of growth after 48 hrs
Cytotoxicity against human Hep2 cells in log phase of growth after 48 hrs
|
[PMID: 24709561] |
| HEp-2 | IC50 |
49.4 μM
Compound: 8
|
Cytotoxicity against human Hep2 cells in lag phase of growth after 48 hrs
Cytotoxicity against human Hep2 cells in lag phase of growth after 48 hrs
|
[PMID: 24709561] |
| HL-60 | GI50 |
35.26 μM
Compound: 12
|
Cytotoxicity against human HL60 cells assessed as growth inhibition by WST-8 assay
Cytotoxicity against human HL60 cells assessed as growth inhibition by WST-8 assay
|
[PMID: 24210499] |
| HL-60 | IC50 |
>10 μM
Compound: 16
|
Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 48 hrs by MTS assay
Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 48 hrs by MTS assay
|
[PMID: 33978415] |
| MCF7 | IC50 |
>10 μM
Compound: 16
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTS assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTS assay
|
[PMID: 33978415] |
| MRC5 | GI50 |
40.19 μM
Compound: 12
|
Cytotoxicity against human MRC5 cells assessed as growth inhibition by WST-8 assay
Cytotoxicity against human MRC5 cells assessed as growth inhibition by WST-8 assay
|
[PMID: 24210499] |
| PANC-1 | GI50 |
43.14 μM
Compound: 12
|
Cytotoxicity against human PANC1 cells assessed as growth inhibition by WST-8 assay
Cytotoxicity against human PANC1 cells assessed as growth inhibition by WST-8 assay
|
[PMID: 24210499] |
| PC-3 | GI50 |
41.03 μM
Compound: 12
|
Cytotoxicity against human PC3 cells assessed as growth inhibition by WST-8 assay
Cytotoxicity against human PC3 cells assessed as growth inhibition by WST-8 assay
|
[PMID: 24210499] |
| RAW264.7 | IC50 |
15.5 μM
Compound: 38
|
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay
|
[PMID: 29924604] |
| SMMC-7721 | IC50 |
>10 μM
Compound: 16
|
Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability after 48 hrs by MTS assay
Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability after 48 hrs by MTS assay
|
[PMID: 33978415] |
| SW480 | IC50 |
>10 μM
Compound: 16
|
Cytotoxicity against human SW480 cells assessed as reduction in cell viability after 48 hrs by MTS assay
Cytotoxicity against human SW480 cells assessed as reduction in cell viability after 48 hrs by MTS assay
|
[PMID: 33978415] |
| Vero | IC50 |
47.5 μM
Compound: 8
|
Cytotoxicity against African green monkey Vero cells in lag phase of growth after 48 hrs
Cytotoxicity against African green monkey Vero cells in lag phase of growth after 48 hrs
|
[PMID: 24709561] |
| Vero | IC50 |
47.5 μM
Compound: 8
|
Cytotoxicity against African green monkey Vero cells in log phase of growth after 48 hrs
Cytotoxicity against African green monkey Vero cells in log phase of growth after 48 hrs
|
[PMID: 24709561] |
Chemical Information
-
CAS. Nr. 88664-08-8
-
Molecular Weight 316.43
-
Formel C20H28O3
-
SMILES
C[C@@]12C3=C(O)C(O)=C(C(C)C)C=C3C(C[C@@]1([H])C(C)(CCC2)C)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)